Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2006
Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivoCristina Müller, Matthias Brühlmeier, P August Schubiger, et al.
The Journal of Biological Chemistry|May 21, 2004
Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domainMonika Heiz, Jürgen Grünberg, P August Schubiger, et al.
Nuclear Medicine and Biology|October 19, 2006
Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo propertiesKarin Knogler, Jürgen Grünberg, Ilse Novak-Hofer, et al.
Nuclear Medicine and Biology|November 14, 2007
Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5Michael Honer, Anja Stoffel, Lea J Kessler, et al.
Nuclear Medicine and Biology|May 28, 2003
Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imagingKurt Zimmermann, Jürgen Grünberg, Michael Honer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2008
A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumoursElisa García-Garayoa, Peter Bläuenstein, Alain Blanc, et al.
Bioconjugate Chemistry|January 20, 2005
Synthesis and in vitro characterization of organometallic rhenium and technetium glucose complexes against Glut 1 and hexokinaseRoger Schibli, Cécile Dumas, Jeannine Petrig, et al.
Nuclear Medicine and Biology|May 25, 2006
Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumorsElisa García-Garayoa, Veronique Maes, Peter Bläuenstein, et al.
Nuclear Medicine and Biology|August 4, 2009
Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5Christophe Lucatelli, Michael Honer, Jean-Frédéric Salazar, et al.
European Journal of Medicinal Chemistry|March 21, 2006
Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptorsLinjing Mu, Konstantin Drandarov, William H Bisson, et al.
Pageof 5